PDLIM7 and nasopharyngeal carcinoma: Smith and colleagues reported a phase I trial with T cells generated by an adenovirus-based vector, AdE1-LMPpoly, which expands LMP1&2- and EBNA1-specific T cells also in EBV-positive advanced NPC.